Sovran Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Sovran Advisors’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$714K	Buy	13,553 +2,234	+20%	+$113K	0.05%	303
2026 Q1	$578K	Sell	11,319 -570	-5%	-$33.5K	0.05%	333
2025 Q4	$742K	Buy	11,889 +75	+0.6%	+$4.63K	0.06%	275
2025 Q3	$717K	Sell	11,814 -430	-4%	-$26.3K	0.06%	270
2025 Q2	$753K	Sell	12,244 -209	-2%	-$12.6K	0.08%	249
2025 Q1	$709K	Sell	12,453 -1,708	-12%	-$106K	0.09%	226
2024 Q4	$846K	Buy	+14,161	New	+$842K	0.12%	173

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Sovran Advisors's IHI Position: Q2 2026 in Review

Sovran Advisors increased its iShares US Medical Devices ETF (IHI) stake by 20% in Q2 2026, buying an estimated $113K and bringing the position to 13,553 shares worth $714K. The position accounts for 0.05% of the portfolio, ranked #303.

Sovran Advisors first reported a position in IHI in Q4 2024 and has held it in 7 quarters since. The position peaked at $846K in Q4 2024. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

Sovran Advisors held 13,553 shares of iShares US Medical Devices ETF worth $714K as of Q2 2026.
Sovran Advisors bought 2,234 iShares US Medical Devices ETF shares in Q2 2026, an estimated $113K.
iShares US Medical Devices ETF made up 0.05% of Sovran Advisors's portfolio in Q2 2026, its #303 holding.
Sovran Advisors first reported a position in iShares US Medical Devices ETF in Q4 2024 and has held it in 7 quarters since.
Sovran Advisors's iShares US Medical Devices ETF position peaked at $846K in Q4 2024.
501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Sovran Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.